Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2026-01-17 @ 6:19 AM
Study NCT ID:
NCT00072592
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
2003-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Wegener's Granulomatosis | View |